Victory Capital Management Inc. Acquires 102,764 Shares of Cabot Corporation $CBT

Victory Capital Management Inc. boosted its stake in shares of Cabot Corporation (NYSE:CBT) by 259.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 142,404 shares of the specialty chemicals company’s stock after buying an additional 102,764 shares during the period. Victory Capital Management Inc. owned approximately 0.27% of Cabot worth $10,830,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CBT. NewEdge Advisors LLC raised its holdings in shares of Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after acquiring an additional 947 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares during the period. Empowered Funds LLC lifted its holdings in shares of Cabot by 102.6% in the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after purchasing an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after purchasing an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Trading Down 1.4%

NYSE CBT opened at $67.78 on Thursday. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $85.64. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The stock has a 50 day moving average of $73.03 and a 200-day moving average of $71.19. The company has a market cap of $3.54 billion, a PE ratio of 11.87, a PEG ratio of 9.06 and a beta of 0.86.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.13. The business had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The firm’s revenue for the quarter was down 11.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.76 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, February 27th. Cabot’s dividend payout ratio (DPR) is 31.52%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CBT shares. Mizuho set a $75.00 target price on Cabot and gave the company a “neutral” rating in a research report on Wednesday, February 4th. JPMorgan Chase & Co. lowered their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. UBS Group increased their target price on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $73.75.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.